Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BioNTech (BNTX)

BioNTech SE
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BNTX
DateTimeSourceHeadlineSymbolCompany
14/01/202511:58Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
14/01/202511:45GlobeNewswire Inc.BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:BNTXBioNTech SE
27/12/202412:25Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
27/12/202412:21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
13/12/202422:56Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
13/12/202421:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
11/12/202422:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
09/12/202423:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
06/12/202422:57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
27/11/202422:50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
26/11/202423:37Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
25/11/202422:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
15/11/202422:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
14/11/202412:38Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
13/11/202422:00Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BNTXBioNTech SE
13/11/202411:49Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
13/11/202411:45GlobeNewswire Inc.BioNTech to Acquire Biotheus to Boost Oncology StrategyNASDAQ:BNTXBioNTech SE
12/11/202412:39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
04/11/202411:57Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
04/11/202411:53Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
04/11/202411:45GlobeNewswire Inc.BioNTech Announces Third Quarter 2024 Financial Results and Corporate UpdateNASDAQ:BNTXBioNTech SE
31/10/202411:45GlobeNewswire Inc.BioNTech to Host Innovation Series R&D Day on November 14, 2024NASDAQ:BNTXBioNTech SE
21/10/202410:45GlobeNewswire Inc.BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024NASDAQ:BNTXBioNTech SE
18/10/202413:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
16/10/202421:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
15/10/202412:41Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
11/10/202420:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
10/10/202420:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
09/10/202420:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
08/10/202420:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
 Showing the most relevant articles for your search:NASDAQ:BNTX